OrphanDrug
OrphanDrug
Pharma Knowledge Base

Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency

ORPHA: 276603

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

Orphanet Code

ORPHA:276603
Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency
OrphanetORPHA:276603
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO